# Farmers National Banc Corp: financial statements, quarterly

FMNB · Nasdaq · CIK 709337 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmnb.md) · [Financials](/companies/fmnb/financials.md) · [Filings](/companies/fmnb/filings.md) · [Insiders](/companies/fmnb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmnb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [63.4](/filings/0001437749-25-015366.md) | [66.5](/filings/0001437749-25-025282.md) | [70.3](/filings/0001437749-25-033486.md) | [69.3 d](/filings/0001437749-26-007084.md) | [67.8](/filings/0001437749-26-015423.md) | [69.8](/filings/0001437749-26-026085.md) | [70.8](/filings/0001437749-25-033486.md) | [71.5 d](/filings/0001437749-26-007084.md) | [80.8](/filings/0001437749-26-015423.md) | [101](/filings/0001437749-26-026085.md) |
| Interest expense | $m | [20.5](/filings/0000950170-23-060782.md) | [22.2 d](/filings/0000950170-24-027780.md) | [23.4](/filings/0000950170-24-056702.md) | [24.8](/filings/0000950170-24-093421.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.3](/filings/0000950170-24-123299.md) | [3.2 d](/filings/0001437749-26-007084.md) | [2.2](/filings/0001437749-25-015366.md) | [2.4](/filings/0001437749-25-025282.md) | [1.6](/filings/0001437749-25-033486.md) | [3.3 d](/filings/0001437749-26-007084.md) | [2.8](/filings/0001437749-26-015423.md) | [2.4](/filings/0001437749-26-026085.md) | [2.2](/filings/0001437749-25-033486.md) | [3.1 d](/filings/0001437749-26-007084.md) | [3.7](/filings/0001437749-26-015423.md) | [4.1](/filings/0001437749-26-026085.md) |
| Net income | $m | [13.3](/filings/0000950170-24-123299.md) | [14.6 d](/filings/0001437749-26-007084.md) | [11.2](/filings/0001437749-25-033486.md) | [11.8](/filings/0001437749-25-033486.md) | [8.5](/filings/0001437749-25-033486.md) | [14.4 d](/filings/0001437749-26-007084.md) | [13.6](/filings/0001437749-26-026085.md) | [13.9](/filings/0001437749-26-026085.md) | [12.5](/filings/0001437749-25-033486.md) | [14.6 d](/filings/0001437749-26-007084.md) | [16.3](/filings/0001437749-26-026085.md) | [23.0](/filings/0001437749-26-026085.md) |
| Diluted EPS | $ per share | [0.36](/filings/0000950170-24-123299.md) | not reported | [0.30](/filings/0001437749-25-015366.md) | [0.31](/filings/0001437749-25-025282.md) | [0.23](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.37](/filings/0001437749-26-026085.md) | [0.33](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.39](/filings/0001437749-26-026085.md) |
| Basic EPS | $ per share | [0.36](/filings/0000950170-24-123299.md) | not reported | [0.30](/filings/0001437749-25-015366.md) | [0.32](/filings/0001437749-25-025282.md) | [0.23](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.37](/filings/0001437749-26-026085.md) | [0.33](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.39](/filings/0001437749-26-026085.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [4,971](/filings/0000950170-23-060782.md) | [5,078](/filings/0000950170-25-034480.md) | [5,080](/filings/0000950170-24-056702.md) | [5,157](/filings/0000950170-24-093421.md) | [5,237](/filings/0000950170-24-123299.md) | [5,119](/filings/0001437749-26-007084.md) | [5,157](/filings/0001437749-25-015366.md) | [5,178](/filings/0001437749-25-025282.md) | [5,236](/filings/0001437749-25-033486.md) | [5,246](/filings/0001437749-26-026085.md) | [7,175](/filings/0001437749-26-015423.md) | [7,141](/filings/0001437749-26-026085.md) |
| Total liabilities | $m | [4,655](/filings/0000950170-23-060782.md) | [4,674](/filings/0000950170-25-034480.md) | [4,683](/filings/0000950170-24-056702.md) | [4,760](/filings/0000950170-24-093421.md) | [4,797](/filings/0000950170-24-123299.md) | [4,713](/filings/0001437749-26-007084.md) | [4,728](/filings/0001437749-25-015366.md) | [4,741](/filings/0001437749-25-025282.md) | [4,770](/filings/0001437749-25-033486.md) | [4,760](/filings/0001437749-26-026085.md) | [6,409](/filings/0001437749-26-015423.md) | [6,357](/filings/0001437749-26-026085.md) |
| Long-term debt | $m | [88.6](/filings/0000950170-23-060782.md) | [88.7](/filings/0000950170-25-034480.md) | [88.8](/filings/0000950170-24-056702.md) | [88.9](/filings/0000950170-24-093421.md) | [86.0](/filings/0000950170-24-123299.md) | [86.2](/filings/0001437749-26-007084.md) | [86.3](/filings/0001437749-25-015366.md) | [86.4](/filings/0001437749-25-025282.md) | [86.6](/filings/0001437749-25-033486.md) | [86.7](/filings/0001437749-26-026085.md) | [94.1](/filings/0001437749-26-015423.md) | [94.4](/filings/0001437749-26-026085.md) |
| Short-term borrowings | $m | [0.0](/filings/0000950170-23-060782.md) | [355](/filings/0000950170-25-034480.md) | [345](/filings/0000950170-24-056702.md) | [406](/filings/0000950170-24-093421.md) | [285](/filings/0000950170-24-123299.md) | [305](/filings/0001437749-26-007084.md) | [102](/filings/0001437749-25-015366.md) | [203](/filings/0001437749-25-025282.md) | [235](/filings/0001437749-25-033486.md) | [281](/filings/0001437749-26-026085.md) | [341](/filings/0001437749-26-015423.md) | [361](/filings/0001437749-26-026085.md) |
| Shareholders' equity | $m | [316](/filings/0000950170-24-123299.md) | [404](/filings/0001437749-26-007084.md) | [397](/filings/0001437749-25-033486.md) | [397](/filings/0001437749-25-033486.md) | [440](/filings/0001437749-25-033486.md) | [406](/filings/0001437749-26-026085.md) | [429](/filings/0001437749-26-026085.md) | [438](/filings/0001437749-26-026085.md) | [466](/filings/0001437749-25-033486.md) | [486](/filings/0001437749-26-026085.md) | [767](/filings/0001437749-26-026085.md) | [784](/filings/0001437749-26-026085.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.0 d](/filings/0000950170-24-123299.md) | [14.5 d](/filings/0001437749-26-007084.md) | [13.7](/filings/0001437749-25-015366.md) | [16.6 d](/filings/0001437749-25-025282.md) | [23.9 d](/filings/0001437749-25-033486.md) | [12.4 d](/filings/0001437749-26-007084.md) | [15.7](/filings/0001437749-26-015423.md) | [14.0 d](/filings/0001437749-26-026085.md) | [10.7 d](/filings/0001437749-25-033486.md) | [19.6 d](/filings/0001437749-26-007084.md) | [7.6](/filings/0001437749-26-015423.md) | [26.5 d](/filings/0001437749-26-026085.md) |
| Capital expenditure | $m | not reported | not reported | [1.6](/filings/0001437749-25-015366.md) | [2.2 d](/filings/0001437749-25-025282.md) | [3.5 d](/filings/0001437749-25-033486.md) | [4.4 d](/filings/0001437749-26-007084.md) | [3.5](/filings/0001437749-26-015423.md) | [1.6 d](/filings/0001437749-26-026085.md) | [1.7 d](/filings/0001437749-25-033486.md) | [1.1 d](/filings/0001437749-26-007084.md) | [0.5](/filings/0001437749-26-015423.md) | [0.6 d](/filings/0001437749-26-026085.md) |
| Dividends paid | $m | [6.3 d](/filings/0000950170-24-123299.md) | [6.3 d](/filings/0000950170-25-034480.md) | [6.3](/filings/0000950170-24-056702.md) | [6.3 d](/filings/0000950170-24-093421.md) | [6.4 d](/filings/0000950170-24-123299.md) | [6.4 d](/filings/0000950170-25-034480.md) | [6.4](/filings/0001437749-26-015423.md) | [6.4 d](/filings/0001437749-26-026085.md) | [6.4 d](/filings/0001437749-25-033486.md) | [6.4 d](/filings/0001437749-26-007084.md) | [6.4](/filings/0001437749-26-015423.md) | [10.0 d](/filings/0001437749-26-026085.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-123299.md) | [0.0 d](/filings/0001437749-26-007084.md) | [0.0](/filings/0000950170-24-056702.md) | [0.0 d](/filings/0000950170-24-093421.md) | [0.0 d](/filings/0000950170-24-123299.md) | [0.0 d](/filings/0001437749-26-007084.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.9](/filings/0000950170-23-060782.md) | [37.9](/filings/0000950170-24-056702.md) | [37.3](/filings/0000950170-24-093421.md) | [37.4](/filings/0000950170-24-123299.md) | [37.5](/filings/0001437749-25-015366.md) | [37.5](/filings/0001437749-25-025282.md) | [37.6](/filings/0001437749-25-033486.md) | [37.6](/filings/0001437749-26-015423.md) | [37.6](/filings/0001437749-26-026085.md) | [37.7](/filings/0001437749-25-033486.md) | [44.9](/filings/0001437749-26-015423.md) | [59.2](/filings/0001437749-26-026085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,247,572 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.